/ 06.06.2014 02:55PM Quantel to Color Finish 4K 60p FIFA World Cup Pablo Rio and Genetic Engineering 2 tapped The Quantel GE2 system, which includes two Pablo Rio 4KO color correction and finishing systems sharing storage and workflow via a GenePool, will be used for the production of fast-turnaround 4K highlights packages. These will be distributed to broadcasters and Sony Stores worldwide as well as being displayed on 4K super-screens in fan parks around Brazil. The Quantel system will also be used for the post production of the Official FIFA World Cup film in 4K Ultra HD. Pablo Rio runs on high-performance PC hardware and exploits Nvidia Maximus multi-GPU technology to deliver interactivity and productivity. Pablo Rio is available as software-only and as a range of Quantel-backed turnkey systems. Genetic Engineering 2 provides shared storage and workflow for up to four Pablo Rio systems. The Quantel system will work with 4K 60p XAVC media recorded on either the Sony PMW-F55 cameras being used by FIFA Film crews throughout the competition or the Sony Servers used for the 4K live production of three matches played at the Maracana Stadium in Rio de Janeiro (one in the round of 16, one quarter … Continue reading →

TIME Health Heart Disease Doctors, and especially doctors who do research, dont like to use the words cure or eradicate. They know how dangerous that can be, since the human body is so unpredictable. But Dr. Kiran Musunuru is showing some uncharacteristic swagger about his latest success in lowering heart attack risk among some lucky mice. Taking advantage of advances in genetic engineering, a team lead by Musunuru, who holds positions at Harvard Universitys Department of Stem Cell and Regenerative Biology and Brigham and Womens Hospital, have edited the genomes of mice and successfully protected them from heart disease. The results, published in the journal Circulation Research, hint at an entirely new way of avoiding the leading killer of Americans by possibly cutting heart attack risk by up to 90%. What has me excited as a cardiologist is that my goal is eradicating disease, says Musunuru. There is no bolder way I can put it. I want to eradicate the disease and this offers one potential way to do it. MORE: Experimental Cholesterol-Lowering Drug Shows Promise He admits that it may be 10 years or more before the technique is ready for testing in people, but these first results are … Continue reading →